Tag: porcine vaccine market analysis

  • 2024-2033 Porcine Vaccine Market Forecast: Predicted Growth Rate and Market Size

    2024-2033 Porcine Vaccine Market Forecast: Predicted Growth Rate and Market Size

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    How Rapidly is the Porcine Vaccine Market Forecasted to Grow Between 2024 and 2033?

    In recent times, the porcine vaccine market has exhibited substantial growth. The market, which is expected to catapult from $1.74 billion in 2023 to $1.91 billion in 2024, will exhibit a compound annual growth rate (CAGR) of 9.5%. The historic expansion of the market can be linked to disease outbreaks and the implementation of control measures, a worldwide rise in pork intake, the surge in pig farming, government-led disease control initiatives, and awareness and education programs.

    The pigs vaccine market is projected to experience robust expansion in the coming years, with expectations of escalating to $2.73 billion by 2028, marking a 9.4% compound annual growth rate (CAGR). This anticipated expansion during the forecast period is linked to the worldwide growth of pig agriculture, escalating disease issues, strict regulatory measures and adherence to these, advancements in vaccine technology, international trade dynamics and efforts at disease risk reduction. Notable trends for the forecast period encompass the tailoring of vaccines to local challenges, the incorporation of biotechnology in vaccine formulation, increasing alarm over diseases transferable from animals to humans, implementation of genomic methodologies in vaccine development, and surge in research and development investment.

    Claim Your Free Sample of the Global Porcine Vaccine Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=9111&type=smp

    What Factors Are Behind the Rapid Growth of the porcine vaccine Market?

    The escalating prevalence of swine diseases is expected to drive the growth of the porcine vaccine market. Swine influenza, more commonly known as swine flu, is a prevalent respiratory disease in pigs, typically instigated by the type A influenza virus, which often results in influenza epidemics among pigs. Porcine vaccines are administered to pigs and stimulate an immunogenic reaction, enabling pigs’ immune systems to recognize the disease-caaling agent. This process enables the pig’s immune system to combat subsequent infections from pathogens and triggers an anamnestic response to prevent disease when exposed to the same pathogen again. In a recent example, the Swine Health Information Centre, a US-based organization dedicated to protecting and improving swine health, noted in their December 2021 report that European countries reported 1,844 outbreaks of African Swine Fever (ASF) in 2021. It follows that the increased incidence of swine disease is a significant driver for the porcine vaccine market.

    What Are the Principal Segments of the Porcine Vaccine Market?

    1) By Technology: Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, DNA Vaccines

    2) By Disease Indication: Diarrhea, Swine Influenza, Arthritis, Bordetella Rhinitis, Porcine Reproductive and Respiratory Virus (PRRSV), Porcine Circovirus Associated Disease (PCVAD), Other Disease Indications

    3) By End User: Veterinary Hospitals, Hog or Pig Production Farm

    Order Now for Fast Delivery of Your Porcine Vaccine Market Report!

    https://www.thebusinessresearchcompany.com/report/porcine-vaccine-global-market-report

    Which Geographical Regions Are Shaping the Porcine Vaccine Market Growth?

    North America is the largest region in the porcine vaccine market in 2023. The regions covered in the porcine vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Porcine Vaccine Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the porcine vaccine market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Porcine Vaccine Market Include

    1. Porcine Vaccine Market Executive Summary

    2. Porcine Vaccine Market Segments

    3. Porcine Vaccine Market Size And Template Market Growth Rate

    4. Key Porcine Vaccine Market Trends

    5. Major Porcine Vaccine Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Porcine Vaccine Market

    26. Top Porcine Vaccine Companies

    27. Porcine Vaccine Market Opportunities And Strategies

    28. Porcine Vaccine Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Veterinary Vaccines Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report

    Veterinary Pain Management Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/veterinary-pain-management-global-market-report

    Veterinary Antibiotics Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/veterinary-antibiotics-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Overview Of The Porcine Vaccine Market 2024-2033: Growth And Major Players Analysis

    Overview Of The Porcine Vaccine Market 2024-2033: Growth And Major Players Analysis

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    The porcine vaccine market has shown robust growth over recent years and is expected to continue this trend. This blog delves into the factors driving this growth, key trends, and future projections for the market.

    Recent Market Growth and Projections

    • Market Size and Growth Rate:
      • The porcine vaccine market grew from $1.74 billion in 2023 to $1.91 billion in 2024, with a CAGR of 9.5%.
      • By 2028, the market is projected to reach $2.73 billion, growing at a CAGR of 9.4%.
    • Historical Growth Drivers:
      • Disease outbreaks and control measures.
      • Global increase in pork consumption.
      • Intensification of pig farming.
      • Government initiatives for disease control.
      • Awareness and education programs.

    Future Market Growth Drivers

    • Global Expansion of Pig Farming:
      • Increasing demand for pork worldwide drives expansion of pig farming operations.
    • Rising Disease Challenges:
      • New and recurring disease threats necessitate advanced vaccine solutions.
    • Stringent Regulations and Compliance:
      • Government regulations on animal health and safety push for effective vaccination programs.
    • Technological Advancements in Vaccine Development:
      • Innovations in biotechnology and genomic approaches enhance vaccine efficacy and customization.
    • Global Trade and Disease Risk Mitigation:
      • Global pork trade requires robust disease control measures to prevent outbreaks.

    View More On The Porcine Vaccine Market Report 2024 – https://www.thebusinessresearchcompany.com/report/porcine-vaccine-global-market-report

    Trends Shaping the Future of Porcine Vaccines

    • Customization of Vaccines for Regional Challenges:
      • Tailoring vaccines to address specific regional disease threats.
    • Integration of Biotechnology in Vaccine Development:
      • Utilizing biotech for more precise and effective vaccine formulations.
    • Rising Concerns About Zoonotic Diseases:
      • Increased focus on preventing diseases that can transfer from animals to humans.
    • Application of Genomic Approaches in Vaccine Design:
      • Genomic technologies aid in developing more targeted and effective vaccines.
    • Growing Investments in Research and Development:
      • Increased funding for innovative vaccine research and development.

    Surging Swine Disease Infections Fuel Growth

    • Swine Disease Infections:
      • Rising infections, such as swine influenza (swine flu), drive demand for vaccines.
      • Swine influenza is commonly caused by the type A influenza virus, leading to frequent outbreaks.
    • Vaccine Mechanism:
      • Porcine vaccines stimulate the pig’s immune system, preparing it to fight pathogens and prevent sickness.
    • Case Example:
      • In December 2021, European countries reported 1,844 outbreaks of African Swine Fever (ASF), highlighting the need for effective vaccines.

    Key Players in the Porcine Vaccine Market

    • Major Companies:
      • Bayer AG
      • Sanofi Pasteur Inc.
      • Eli Lilly and Company
      • Boehringer Ingelheim International GmbH
      • Zoetis Inc.
      • Arko Laboratories Limited
      • Merck Animal Health
      • Elanco Animal Health Incorporated
      • Ceva Santé Animale
      • Huvepharma Inc.

    Innovative Advancements in Swine Health

    • Flex ParvoPRRS Vaccine:
      • Launched by Boehringer Ingelheim in September 2021, it combines protection against PRRS and Porcine Parvovirus.
      • Designed to improve reproductive health and productivity in pigs, supporting mass vaccination strategies.

    Strategic Acquisitions and Market Expansion

    • Vaxxinova International BV Acquisition of Newport Labs:
      • In October 2021, Vaxxinova International BV acquired Newport Labs to enhance its product portfolio and expand its presence in the swine and cattle disease market.

    Market Segmentation

    • By Technology:
      • Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, DNA Vaccines.
    • By Disease Indication:
      • Diarrhea, Swine Influenza, Arthritis, Bordatella Rhinitis, PRRSV, PCVAD, Other Disease Indications.
    • By End User:
      • Veterinary Hospitals, Hog or Pig Production Farms.

    Regional Market Insights

    • North America:
      • North America was the largest region in the porcine vaccine market in 2023.

    Conclusion

    The porcine vaccine market is set for significant growth, driven by increasing disease challenges, technological advancements, and a global expansion of pig farming. With continuous innovations and strategic acquisitions, the market is well-positioned to address the evolving needs of swine health management.

    Request A Sample Of The Global Porcine Vaccine Market Report 2024:

    https://www.thebusinessresearchcompany.com/sample_request?id=9111&type=smp